These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 21724383)

  • 1. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
    Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
    Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
    Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
    Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
    Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.
    Proctor MJ; McMillan DC; Horgan PG; Fletcher CD; Talwar D; Morrison DS
    PLoS One; 2015; 10(3):e0116206. PubMed ID: 25730322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostication in advanced cancer: a study examining an inflammation-based score.
    Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
    J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of the role of inflammation in renal cancer.
    Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
    Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.
    Proctor MJ; Morrison DS; Talwar D; Balmer SM; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
    Br J Cancer; 2011 Feb; 104(4):726-34. PubMed ID: 21266974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.
    Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P
    Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
    Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
    J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
    Meek CL; Wallace AM; Forrest LM; McMillan DC
    Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.